$35.980
-0.011 (-0.03%)Zum Schluss
GMRE-News
GMRE-Events
Global Medical REIT Announces Q3 FFO of $1.00, Below Consensus Estimate of $1.05
Reports Q3 adjusted FFO $1.12. Reports Q3 revenue $37.04M, consensus $38.15M.
Global Medical REIT announces $50M buyback, 1-for-5 reverse stock split
On August 12, 2025, the Board approved a $50 million common stock repurchase program. Under the Program, the Company may purchase up to $50 million of its outstanding shares of common stock, par value $0.001 per share, from time to time in the open market, including through block purchases, through privately negotiated transactions or pursuant to any Rule 10b5-1 trading plan, in accordance with applicable securities laws. On August 12, 2025, the Board also approved a reverse stock split of the Company's outstanding shares of Common Stock at a ratio of one-for-five. The Reverse Stock Split is expected to take effect as of 5:00 p.m. Eastern Time on September 19, 2025.
Global Medical REIT reports Q2 adjusted FFO 23c, consensus 23c
Reports Q2 revenue $37.9M, consensus $35.57M. Mark Decker, Jr., Chief Executive Officer and President stated, "I'm excited to be on board as we report our first quarter as a new team here at Global Medical. We have an outstanding niche and I look forward to honing that further and driving results for all our stakeholders in the coming years. For a fulsome discussion of the business, please join our call tomorrow."
Global Medical REIT CEO Jeffrey Busch to leave role, Mark Decker to succeed
Global Medical REIT announced that Mark Decker has been appointed as the company's CEO and president, effective immediately. Decker, who will join the board of directors, succeeds Jeffrey Busch, who will continue to serve on the board as non-executive chairman. Decker joins the company from Proterra Investment Partners, where he founded and co-led their net lease real estate investment strategy.
Global Medical REIT reports Q1 AFFO 22c, consensus 22c
Reports Q1 revenue $34.62M, consensus $35.48M. Jeffrey M. Busch, Chairman, Chief Executive Officer and President stated, "During the first quarter, we continued to deliver steady results supported by the high quality of our portfolio and stability of our tenant base. I'm pleased to announce we have completed the acquisition of the five-property portfolio we announced in the fourth quarter of last year. These properties are a great strategic fit to our existing portfolio given (i) the procedural-based nature of the tenants' specialties (including cardiology, gastroenterology, imaging and oncology tenants) and the close proximity of the buildings to hospital campuses, each of which promotes tenant retention, and (ii) that almost 70% of the leases are triple-net leases. We utilized our deep relationships in the industry to win the bidding for this portfolio at an attractive cap rate of 9.0%, which further demonstrates our ability to acquire properties in a higher cost of capital environment. I am extremely proud of this acquisition and, with our strong liquidity position, we will continue to actively monitor the transaction market for acquisition opportunities that meet our disciplined investment criteria. As I transition from my role as CEO, I would like to express my appreciation to the entire GMRE family for their dedication and contributions to our shared success."
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.